International Assets Investment Management LLC Has $980,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

International Assets Investment Management LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the second quarter, Holdings Channel.com reports. The firm owned 2,204 shares of the medical equipment provider’s stock after selling 30 shares during the quarter. International Assets Investment Management LLC’s holdings in Intuitive Surgical were worth $980,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Gilbert & Cook Inc. grew its stake in Intuitive Surgical by 6.5% in the fourth quarter. Gilbert & Cook Inc. now owns 3,437 shares of the medical equipment provider’s stock valued at $1,160,000 after purchasing an additional 211 shares in the last quarter. Mather Group LLC. increased its holdings in Intuitive Surgical by 4.7% during the fourth quarter. Mather Group LLC. now owns 1,685 shares of the medical equipment provider’s stock worth $568,000 after buying an additional 76 shares during the last quarter. Choreo LLC raised its position in Intuitive Surgical by 98.1% during the fourth quarter. Choreo LLC now owns 2,015 shares of the medical equipment provider’s stock worth $680,000 after acquiring an additional 998 shares in the last quarter. Van ECK Associates Corp lifted its stake in Intuitive Surgical by 5.6% in the fourth quarter. Van ECK Associates Corp now owns 56,513 shares of the medical equipment provider’s stock valued at $19,065,000 after acquiring an additional 3,018 shares during the last quarter. Finally, Kestra Private Wealth Services LLC grew its position in shares of Intuitive Surgical by 9.9% in the 4th quarter. Kestra Private Wealth Services LLC now owns 4,140 shares of the medical equipment provider’s stock valued at $1,397,000 after acquiring an additional 373 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on ISRG shares. Citigroup boosted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Stifel Nicolaus increased their price target on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Piper Sandler lifted their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Truist Financial increased their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $446.45.

Intuitive Surgical Stock Performance

ISRG opened at $492.63 on Friday. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $493.97. The firm has a market cap of $174.74 billion, a P/E ratio of 88.92, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39. The business’s fifty day moving average is $453.49 and its 200-day moving average is $413.69.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total transaction of $575,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total transaction of $575,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,655,048.26. The disclosure for this sale can be found here. Insiders have sold 55,552 shares of company stock valued at $26,281,657 over the last three months. 0.90% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.